Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced liver fibrosis (ELF) score predicts hepatic decompensation and mortality.

JHEP reports : innovation in hepatology·2024
Same author

Oesophageal cell collection device and biomarker testing to identify high-risk Barrett's patients requiring endoscopic investigation.

The British journal of surgery·2024
Same author

Giant electron-mediated phononic nonlinearity in semiconductor-piezoelectric heterostructures.

Nature materials·2024
Same author

Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5-17 years in the United States: a cohort study.

BMC pediatrics·2024
Same author

Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl.

Journal of the American College of Cardiology·2024
Same author

A dual-reference study design for understanding and improving AAV genome size analysis.

Electrophoresis·2024
Same journal

Frailty first: Rethinking invasive strategies for elderly patients with non-ST-elevation myocardial infarction.

World journal of cardiology·2026
Same journal

Ryanodine receptor 2 mutations in catecholaminergic polymorphic ventricular tachycardia: From molecular mechanisms to precision medicine.

World journal of cardiology·2026
Same journal

Oral anticoagulant therapy and outcomes in new-onset atrial fibrillation during acute myocardial infarction: A systematic review and meta-analysis.

World journal of cardiology·2026
Same journal

Phenomenon of "de Winter" pattern, sign, or syndrome: A systematic scoping review and data analysis.

World journal of cardiology·2026
Same journal

Five-year mean follow-up of NeoHexa sirolimus eluting coronary stent: A retrospective evaluation of long-term safety and efficacy.

World journal of cardiology·2026
Same journal

Residual risk in atherosclerotic cardiovascular disease after statin therapy: Clinical mechanisms and management strategies.

World journal of cardiology·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Cardiovascular disease: A global problem extending into the developing world.

Temilolu Olayinka Aje1, Michael Miller

  • 1Temilolu Olayinka Aje, Michael Miller, Division of Cardiology, Department of Medicine, University of Maryland School of Medicine, Rm S3B06, 22 South Greene St., Baltimore, MD 21201, United States.

World Journal of Cardiology
|December 17, 2010
PubMed
Summary
This summary is machine-generated.

Cardiovascular disease (CVD) is a growing global epidemic, especially in developing nations. Addressing CVD requires international collaboration to overcome resource challenges and unique risk factors beyond traditional ones.

Keywords:
Developing worldEpidemicHeart diseasePreventionRisk factorsUrbanization

More Related Videos

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

Related Experiment Videos

Last Updated: Jun 6, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

Area of Science:

  • Public Health
  • Epidemiology
  • Global Health

Background:

  • Cardiovascular disease (CVD) is transitioning from a disease of westernized nations to a global epidemic.
  • Developing countries face unique challenges in managing the increasing prevalence of CVD.
  • Societal implications and resource limitations exacerbate the CVD burden in these regions.

Purpose of the Study:

  • To review the current international status of cardiovascular disease.
  • To elaborate on the increasing prevalence and societal impact of CVD globally.
  • To identify challenges and propose strategies for CVD risk reduction in developing countries.

Main Methods:

  • Literature review and synthesis of current data on cardiovascular disease prevalence.
  • Analysis of traditional and non-traditional risk factors for CVD in diverse populations.
  • Examination of resource and infrastructure challenges impacting CVD management.

Main Results:

  • CVD prevalence is rising in developing countries, driven by both traditional and unique risk factors.
  • Factors like HIV/AIDS, infectious processes, and nutritional deficiencies complicate prevention efforts.
  • Lack of resources and infrastructure hinder the implementation of effective CVD reduction strategies.

Conclusions:

  • Enhanced international partnerships between governments, hospitals, and global societies are crucial.
  • Optimizing standard of care measures is essential for reducing cardiovascular risk in developing nations.
  • A multi-faceted approach addressing unique regional challenges is necessary for global CVD control.